On Friday, President Donald Trump’s White Home launched a brand new COVID-19 web site.
What Occurred: The newly launched web site sharply criticized the pandemic response by the World Well being Group (WHO), former President Joe Biden, and Dr. Anthony Fauci, who was the nation’s prime well being official.
The event was first reported by Reuters.
The web site’s banner declares, “Lab leak – the true origins of COVID-19,” and likewise revisits the continuing debate concerning the origins of the pandemic, particularly pointing to a lab leak in China because the most probably trigger.
“Wuhan Institute of Virology (WIV) researchers had been sick with COVID-like signs within the fall of 2019, months earlier than COVID-19 was found on the moist market,” states one of many 5 factors on the web site.
Why It is Necessary: The president’s overhaul of the net useful resource comes in opposition to the backdrop of Trump’s intensifying commerce conflict with China and continued criticism of previous administrations.
In January, a CIA spokesperson acknowledged that the company believes the COVID-19 pandemic is extra more likely to have originated from a laboratory than by pure transmission, although it holds solely “low confidence” in that evaluation and considers each prospects—lab and pure origins—believable.
The Chinese language authorities has beforehand mentioned that it helps and has participated in efforts to uncover the virus’s origins, whereas accusing the U.S. of politicizing the problem, notably resulting from investigations led by American intelligence businesses.
Earlier this yr, Trump additionally signed an government order to withdraw the U.S. from the WHO, citing issues over governance and monetary practices. This determination continues his first-term efforts to finish WHO membership, a transfer beforehand reversed by Biden in 2021.
Final month, the U.S. Division of Well being and Human Companies introduced a restructuring plan aligned with Trump’s government order, aiming to chop prices and refocus priorities.
This plan contains lowering the workforce by 10,000 staff, saving $1.8 billion yearly.
Learn Subsequent:
Disclaimer: This content material was partially produced with the assistance of Benzinga Neuro and was reviewed and printed by Benzinga editors.
Photograph courtesy: Shutterstock
Market Information and Knowledge dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
